Last quarter (Q4 2023), Galera Therapeutics's total revenue was $―, a decrease of ― from the same quarter last year. In Q4, Galera Therapeutics's net income was $-5.59M. See Galera Therapeutics’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	-	-	-	-	$ 0.00	$ 0.00
Cost of Revenue	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-
Operating Expense	$ 46.95M	$ 46.95M	$ 51.23M	$ 73.37M	$ 70.55M	$ 50.69M
Operating Income	$ -49.26M	$ -49.26M	$ -51.23M	$ -73.37M	$ -70.55M	$ -50.69M
Net Non Operating Interest Income Expense	$ -9.82M	$ -9.82M	$ -11.06M	$ -7.16M	$ -3.71M	$ -1.21M
Other Income Expense	-	-	-	-	$ 25.00K	$ -40.00K
Pretax Income	$ -59.08M	$ -59.08M	$ -62.29M	$ -80.53M	$ -74.23M	$ -51.94M
Tax Provision	-	-	$ 70.00K	-	$ -16.00K	$ -9.00K
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -54.91M	$ -59.08M	$ -62.36M	$ -80.53M	$ -74.22M	$ -59.11M
Basic EPS	$ -1.33	$ -1.33	$ -2.30	$ -3.12	$ -2.98	$ -16.31
Diluted EPS	$ -1.33	$ -1.33	$ -2.30	$ -3.12	$ -2.98	$ -16.31
Basic Average Shares	$ 178.20M	$ 44.55M	$ 27.09M	$ 25.79M	$ 24.87M	$ 3.63M
Diluted Average Shares	$ 178.20M	$ 44.55M	$ 27.09M	$ 25.79M	$ 24.87M	$ 3.63M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 46.95M	$ 46.95M	$ 51.23M	$ 73.37M	$ 70.55M	$ 50.69M
Net Income From Continuing And Discontinued Operation	$ -59.08M	$ -59.08M	$ -62.22M	$ -80.53M	$ -74.22M	$ -51.93M
Normalized Income	$ -23.18M	$ -32.95M	$ -37.64M	-	$ -74.24M	$ -51.89M
Interest Expense	-	-	-	-	$ 4.88M	$ 3.03M
EBIT	$ -47.67M	$ -47.67M	$ -50.72M	$ -73.34M	$ -69.35M	$ -48.91M
EBITDA	$ -47.41M	$ -47.41M	$ -50.61M	$ -72.56M	$ -68.99M	$ -48.64M

Currency in USD

Galera Therapeutics Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing